nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer
|
Ding, Shuning |
|
|
57 |
C |
p. 71-79 |
artikel |
2 |
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience
|
Franzoi, Maria Alice |
|
|
57 |
C |
p. 86-94 |
artikel |
3 |
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab
|
De Sanctis, Rita |
|
|
57 |
C |
p. 80-85 |
artikel |
4 |
Comparing the cost of non-metastatic breast cancer care in a low-income vs a high-income country: A plea for an optimal allocation of health resources in Sub-Saharan Africa
|
Brandão, Mariana |
|
|
57 |
C |
p. 1-4 |
artikel |
5 |
Editorial Board
|
|
|
|
57 |
C |
p. i |
artikel |
6 |
Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan
|
Lin, Yu-Ju |
|
|
57 |
C |
p. 18-24 |
artikel |
7 |
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival
|
Peng, Fei |
|
|
57 |
C |
p. 49-61 |
artikel |
8 |
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
|
Basile, Debora |
|
|
57 |
C |
p. 104-112 |
artikel |
9 |
Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
|
de Blok, Christel JM. |
|
|
57 |
C |
p. 118-122 |
artikel |
10 |
Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review
|
Kolberg, Hans-Christian |
|
|
57 |
C |
p. 95-103 |
artikel |
11 |
Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer
|
Lapidari, Pietro |
|
|
57 |
C |
p. 43-48 |
artikel |
12 |
Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence
|
Li, Yang |
|
|
57 |
C |
p. 62-70 |
artikel |
13 |
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis
|
Ouyang, Qian |
|
|
57 |
C |
p. 36-42 |
artikel |
14 |
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
|
Salvo, Elizabeth M. |
|
|
57 |
C |
p. 5-17 |
artikel |
15 |
Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations
|
Rocco, Nicola |
|
|
57 |
C |
p. 25-35 |
artikel |
16 |
The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy
|
Reitsamer, R. |
|
|
57 |
C |
p. 113-117 |
artikel |